Delivery Order SPE2DB24D2010-SPE2DB25FZSU9

Award Date 11/18/24
Potential Completion Date 11/19/24
Potential Value $19K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $5,372.85. The contract has a firm fixed price pricing type and a period of performance through March 18, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $18,902.33 and provides for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, to support military healthcare programs. The contract is a firm fixed price, delivery order type and has an ultimate completion date of March 11, 2025. The contract is not designated...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,847.70, is for the supply of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of February 14, 2025. This contract is not designated as a set-aside award. Amerisourcebergen Drug Corp holds a larger Indefinite...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract has a ceiling value of $14,793.61 and is a firm fixed-price delivery order, with an ultimate completion date of April 18, 2025. The contract is not set aside and was openly competed. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a $3,557.04 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of March 7, 2025 and is a firm fixed-price contract. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract has a ceiling value of $24,405.50 and a completion date of June 4, 2025. It is a firm fixed-price contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,877.07, is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of November 18, 2024 and is a firm-fixed-price contract. This contract is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,070.72 firm fixed-price contract is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract has a completion date of February 24, 2025. Amerisourcebergen is the prime contractor, and the contract is not designated as a set-aside. The award is associated with a larger Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MULTAQ 400 MG TABLET 60S. The contract has a ceiling value of $15,605.91 and is a Firm Fixed Price contract type with an ultimate completion date of June 9, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is the prime contractor and this order is part of a larger Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, with a ceiling value of $21,194.57 and a performance period ending on July 2, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
  • SPE2DB24D2010
    Indefinite Delivery Contract
  • SPE2DB24D2010-SPE2DB25FZSU9
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract has a firm fixed price of $18,672.41 and a ceiling value of the same amount. The delivery order has a completion date of November 19, 2024. This contract is not designated as a set-aside and is an open competition. Amerisourcebergen Drug Corp is the prime contractor, and the contract is associated with a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, valued at $999,999,999 and running through November 2026. The IDC covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 2/17/25, 9:46 PM